Research
Title : | Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome |
Area of research : | COVID-19 Research, Life Sciences & Biotechnology |
Focus area : | COVID-19 Therapeutics |
Principal Investigator : | Dr Kamal Rawal, Associate Professor, Amity University, Uttar Pradesh |
Timeline Start Year : | 2020 |
Contact info : | kamal.rawal@gmail.com |
Details
Executive Summary : | The study intends to develop artificial intelligence (AI) driven, integrative, antiviral drug repurposing platform. |
Outcome/Output: | A web enabled resource for COVID-19 datasets, information and software has been created for the benefit of the scientific community. Further, a patient-centric cloud-based system to capture side effects and therapeutics of existing drugs used for COVID-19 treatment has been deployed. |
Organizations involved
Implementing Agency : | Amity University, Uttar Pradesh Funding Agency :Department of Science and Technology (DST), Govt of India | |